Company Announcements

Trading Update and Notice of Final Results

Source: RNS
RNS Number : 6522A
23 January 2020



23 January 2020


EMIS Group plc

("EMIS Group" or "the Group")


Trading update


Notice of final results



EMIS Group plc (AIM: EMIS.L), the UK leader in connected healthcare software and systems, today announces a trading update for the year ended 31 December 2019.




Trading for the year was in line with the Board's expectations, with growth in both revenue and adjusted operating profit maintained at similar levels to the half year. 


Divisional review


In EMIS Health, the Group's leading NHS market shares were maintained, and the GP IT Futures English GP Framework renewal process was successfully concluded, as previously announced on 21 October 2019.


EMIS Enterprise continued to make good progress, including in the Patient business, with the controlled roll-out of new functionality within its Patient Access app completing the first phase of the connected healthcare marketplace.


As previously indicated, the Group continues to invest in the development of its next generation EMIS-X software platform. The Group also completed its reorganisation in the second half of the year, while undertaking further productivity and process improvements.


Financial position


The Group has a strong balance sheet with net cash of £31.1m as at 31 December 2019 (31 December 2018: £15.6m).


Notice of final results


The Group intends to announce its results for the year ended 31 December 2019 on 18 March 2020.



For further information, contact:


EMIS Group plc                                                                                Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO


Numis Securities Limited (Nominated Adviser & Broker)          Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black


MHP Communications                                                                     Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo


Information for investors, including analyst consensus forecasts, can be found on the Group's website at


Notes to Editors


EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.


EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.


EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.


EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and UK healthcare blockchain.


EMIS Group's brands include:


•      EMIS Health, supplying innovative and essential technology to 10,000 healthcare organisations, in the number one or number two market positions in each of its major markets;

•      Patient, the UK's leading independent provider of patient-centric medical and well-being information and related transactional services;

•      Egton, providing specialist ICT infrastructure, hardware and engineering services, and non-clinical software into health and social care; and

•      Dovetail Lab, a health technology company developing blockchain software to facilitate the integration of healthcare data.



LEI: 213800K474ZZK76NX913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit